DK0941081T3 - Ny anvendelse af creatin - Google Patents

Ny anvendelse af creatin

Info

Publication number: DK0941081T3
Authority: DK; Denmark
Prior art keywords: creatine; new use; new
Prior art date: 1996-11-19

Application number

DK97951157T

Other languages

English (en)

Inventor

Marco Anelli

Ettore Strumia

Original Assignee

Pharmacia Italia Spa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-11-19

Filing date

1997-11-10

Publication date

2003-04-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11375243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0941081(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-11-10 Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa

2003-04-22 Application granted granted Critical

2003-04-22 Publication of DK0941081T3 publication Critical patent/DK0941081T3/da

Links

CVSVTCORWBXHQV-UHFFFAOYSA-N creatine Chemical compound NC(=[NH2+])N(C)CC([O-])=O CVSVTCORWBXHQV-UHFFFAOYSA-N 0.000 title 2
229960003624 creatine Drugs 0.000 title 1
239000006046 creatine Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Saccharide Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

DK97951157T 1996-11-19 1997-11-10 Ny anvendelse af creatin DK0941081T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IT96MI002408A IT1298420B1 (it)	1996-11-19	1996-11-19	Uso della creatina nell'insufficienza cardio-respiratoria
PCT/EP1997/006225 WO1998022099A2 (en)	1996-11-19	1997-11-10	New use of creatine

Publications (1)

Publication Number	Publication Date
DK0941081T3 true DK0941081T3 (da)	2003-04-22

Family

ID=11375243

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97951157T DK0941081T3 (da)	1996-11-19	1997-11-10	Ny anvendelse af creatin

Country Status (13)

Country	Link
US (1)	US6242490B1 (da)
EP (1)	EP0941081B1 (da)
CN (2)	CN1623534A (da)
AR (1)	AR009425A1 (da)
AT (1)	ATE230983T1 (da)
BR (1)	BR9713514A (da)
DE (1)	DE69718506T2 (da)
DK (1)	DK0941081T3 (da)
ES (1)	ES2191206T3 (da)
IT (1)	IT1298420B1 (da)
PT (1)	PT941081E (da)
RU (1)	RU2202345C2 (da)
WO (1)	WO1998022099A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3384539B2 (ja) *	1997-09-05	2003-03-10	義之内田	喘息治療剤
EP1051914A1 (de) *	1999-05-08	2000-11-15	DSM Fine Chemicals Austria GmbH	Verwendung von Kreatin als Futterzusatz
US9833427B2 (en)	2000-09-14	2017-12-05	Board Of Regents Of The University Of Nebraska	Creatine ester anti-inflammatory compounds and formulations
US20030212136A1 (en) *	2001-09-14	2003-11-13	Vennerstrom Jonathan L.	Creatine ester pronutrient compounds and formulations
US20030212130A1 (en) *	2000-09-14	2003-11-13	Miller Donald W.	Creatine ester anti-inflammatory compounds and formulations
US20040013732A1 (en) *	2001-09-25	2004-01-22	Michael Farber	Starch-based delivery system for creatine
US20080160086A1 (en) *	2004-02-19	2008-07-03	Scepter Holdings, Inc.	Delivery Systems For Calcium
US20060025475A1 (en) *	2004-07-29	2006-02-02	Stanley Antosh	Use of methyl pyruvate for the purpose of increasing muscle energy production.
US20060052448A1 (en) *	2004-09-04	2006-03-09	Mr. Stanley Antosh	Use of methyl pyruvate or methyl pyruvic acid for the treatment of diseases of the nervous system and for protecting a human central nervous system against neuronal degeneration caused by defective intracellular energy production.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2244534B1 (da)	1973-06-27	1977-07-01	Biotherax Lab
US4783530A (en) *	1986-11-13	1988-11-08	Marion Laboratories, Inc.	8-arylxanthines
US5470838A (en) *	1987-10-28	1995-11-28	Pro-Neuron, Inc.	Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
GB9215746D0 (en) *	1992-07-24	1992-09-09	Hultman Eric	A method of increasing creatine supply depot
WO1998000148A1 (de)	1996-06-28	1998-01-08	Ipr-Institute For Pharmaceutical Research Ag	Arzneimittelzubereitungen, enthaltend kreatin mit mindestens einem salz von calcium, magnesium, mangan oder zink

1996
- 1996-11-19 IT IT96MI002408A patent/IT1298420B1/it active IP Right Grant
1997
- 1997-11-10 CN CNA200410079798XA patent/CN1623534A/zh active Pending
- 1997-11-10 CN CN97199783A patent/CN1237904A/zh active Pending
- 1997-11-10 EP EP97951157A patent/EP0941081B1/en not_active Revoked
- 1997-11-10 DE DE69718506T patent/DE69718506T2/de not_active Expired - Fee Related
- 1997-11-10 PT PT97951157T patent/PT941081E/pt unknown
- 1997-11-10 RU RU99112945/14A patent/RU2202345C2/ru not_active IP Right Cessation
- 1997-11-10 WO PCT/EP1997/006225 patent/WO1998022099A2/en not_active Ceased
- 1997-11-10 US US09/284,465 patent/US6242490B1/en not_active Expired - Fee Related
- 1997-11-10 ES ES97951157T patent/ES2191206T3/es not_active Expired - Lifetime
- 1997-11-10 AT AT97951157T patent/ATE230983T1/de not_active IP Right Cessation
- 1997-11-10 DK DK97951157T patent/DK0941081T3/da active
- 1997-11-10 BR BR9713514-3A patent/BR9713514A/pt unknown
- 1997-11-13 AR ARP970105291A patent/AR009425A1/es unknown

Also Published As

Publication number	Publication date
BR9713514A (pt)	2000-02-29
ATE230983T1 (de)	2003-02-15
WO1998022099A3 (en)	1998-07-09
AR009425A1 (es)	2000-04-12
ITMI962408A1 (it)	1998-05-19
CN1623534A (zh)	2005-06-08
CN1237904A (zh)	1999-12-08
PT941081E (pt)	2003-04-30
WO1998022099A2 (en)	1998-05-28
RU2202345C2 (ru)	2003-04-20
EP0941081B1 (en)	2003-01-15
IT1298420B1 (it)	2000-01-05
DE69718506D1 (de)	2003-02-20
DE69718506T2 (de)	2003-07-31
ES2191206T3 (es)	2003-09-01
US6242490B1 (en)	2001-06-05
EP0941081A2 (en)	1999-09-15
ITMI962408A0 (it)	1996-11-19

Publication	Publication Date	Title
NO993068L (no)	1999-06-21	Ny forbindelsesform
DK0914103T3 (da)	2006-10-23	Behandling af hæmoglobinopati
NO982414D0 (no)	1998-05-27	Ny kombinasjon
BR9704713A (pt)	1998-12-15	Combinação estabilizadora
NO20001830D0 (no)	2000-04-07	Ny kombinasjon
ID23198A (id)	2000-03-30	Popok tarik sekali pakai
NO993298L (no)	1999-07-02	Ny fremgangsmÕte
DK1702623T3 (da)	2009-01-19	Anvendelse af interferon-gamma til behandling af hjertehypertrofi
NO995796L (no)	1999-11-26	Ny fremgangsmåte
DK0895782T3 (da)	2005-01-03	Farmaceutiske præparater af cilansetron stabiliseret mod racemisering
FI956015A7 (fi)	1996-06-17	5-asyyli-1,4-dihydropyridiinien käyttö
PT941081E (pt)	2003-04-30	Nova utilizacao de creatina
DE59705708D1 (de)	2002-01-17	Lagebestimmung von peripherieeinheiten
DK0810216T3 (da)	2001-07-23	Derivater af 10,11-dihydro-10-oxo-5H-dibenz/b/,f/azepin-5-carboxamid
DK0689577T3 (da)	1997-03-17	Anvendelse af ferroncen
NO985084D0 (no)	1998-11-02	Vial
DE69733607D1 (de)	2005-07-28	Herstellung von cycloalkyldiarylphosphinen
DK0927163T3 (da)	2007-08-06	Fremstilling af 1-butyl-4-piperidinylmethylamin
FR2744447B1 (fr)	2000-09-29	Utilisation de derives de tetrahydroisoquinoleine
ID17383A (id)	1997-12-24	Penggunaan terbaru turunan turunan sistina
NO993069D0 (no)	1999-06-21	Ny anvendelse av dipeptider
FI974235A0 (fi)	1997-11-14	Ny bestaemningsmetod
DK0913063T3 (da)	2005-08-15	Validering af procedurer
KR970053863U (ko)	1997-10-13	콤파스기능을 갖는 자
KR970062700U (ko)	1997-12-11	락킹 홀더의 구조